ipsen limited

Live EstablishedMegaHealthy

ipsen limited Company Information

Share IPSEN LIMITED

Company Number

06751069

Shareholders

sutrepa sas

Group Structure

View All

Industry

Wholesale of pharmaceutical goods

 

Registered Address

5th floor the point, 37 north wharf road, london, W2 1AF

ipsen limited Estimated Valuation

£111.8m

Pomanda estimates the enterprise value of IPSEN LIMITED at £111.8m based on a Turnover of £122.4m and 0.91x industry multiple (adjusted for size and gross margin).

ipsen limited Estimated Valuation

£33.5m

Pomanda estimates the enterprise value of IPSEN LIMITED at £33.5m based on an EBITDA of £4m and a 8.48x industry multiple (adjusted for size and gross margin).

ipsen limited Estimated Valuation

£44m

Pomanda estimates the enterprise value of IPSEN LIMITED at £44m based on Net Assets of £23.3m and 1.89x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Ipsen Limited Overview

Ipsen Limited is a live company located in london, W2 1AF with a Companies House number of 06751069. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in November 2008, it's largest shareholder is sutrepa sas with a 100% stake. Ipsen Limited is a established, mega sized company, Pomanda has estimated its turnover at £122.4m with healthy growth in recent years.

View Sample
View Sample
View Sample

Ipsen Limited Health Check

Pomanda's financial health check has awarded Ipsen Limited a 2.5 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs

Health Check Image
Health Rating2.5out of 5
positive_score

3 Strong

positive_score

2 Regular

positive_score

6 Weak

size

Size

annual sales of £122.4m, make it larger than the average company (£24.7m)

£122.4m - Ipsen Limited

£24.7m - Industry AVG

growth

Growth

3 year (CAGR) sales growth of 6%, show it is growing at a similar rate (5.3%)

6% - Ipsen Limited

5.3% - Industry AVG

production

Production

with a gross margin of 25.6%, this company has a comparable cost of product (29.5%)

25.6% - Ipsen Limited

29.5% - Industry AVG

profitability

Profitability

an operating margin of 3.2% make it less profitable than the average company (4.1%)

3.2% - Ipsen Limited

4.1% - Industry AVG

employees

Employees

with 96 employees, this is above the industry average (36)

96 - Ipsen Limited

36 - Industry AVG

paystructure

Pay Structure

on an average salary of £121.3k, the company has a higher pay structure (£81.5k)

£121.3k - Ipsen Limited

£81.5k - Industry AVG

efficiency

Efficiency

resulting in sales per employee of £1.3m, this is more efficient (£661.5k)

£1.3m - Ipsen Limited

£661.5k - Industry AVG

debtordays

Debtor Days

it gets paid by customers after 70 days, this is later than average (58 days)

70 days - Ipsen Limited

58 days - Industry AVG

creditordays

Creditor Days

its suppliers are paid after 8 days, this is quicker than average (30 days)

8 days - Ipsen Limited

30 days - Industry AVG

stockdays

Stock Days

it holds stock equivalent to 88 days, this is more than average (65 days)

88 days - Ipsen Limited

65 days - Industry AVG

cashbalance

Cash Balance

There is insufficient data available for this Key Performance Indicator!

- - Ipsen Limited

- - Industry AVG

debtlevel

Debt Level

it has a ratio of liabilities to total assets of 61.1%, this is a higher level of debt than the average (54.4%)

61.1% - Ipsen Limited

54.4% - Industry AVG

IPSEN LIMITED financials

EXPORTms excel logo

Ipsen Limited's latest turnover from December 2023 is £122.4 million and the company has net assets of £23.3 million. According to their latest financial statements, Ipsen Limited has 96 employees and maintains cash reserves of 0 as reported in the balance sheet.

Data source: Companies HousePomanda Estimates

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Turnover122,443,000107,867,000100,188,000103,570,00092,791,00083,900,00070,387,00061,364,00055,506,00052,677,00049,125,00046,018,00040,513,00039,897,00038,136,000
Other Income Or Grants
Cost Of Sales91,132,00076,575,00070,629,00075,949,00066,265,00058,049,00045,790,00039,898,00036,303,00032,574,00030,449,00028,300,00026,325,00024,233,00025,674,000
Gross Profit31,311,00031,292,00029,559,00027,621,00026,526,00025,851,00024,597,00021,466,00019,203,00020,103,00018,676,00017,718,00014,188,00015,664,00012,462,000
Admin Expenses27,367,00028,422,00025,851,00023,116,00023,784,00023,268,00022,934,00019,563,00015,486,00017,683,00016,863,00014,936,04812,443,21115,615,74710,226,000
Operating Profit3,944,0002,870,0003,708,0004,505,0002,742,0002,583,0001,663,0001,903,0003,717,0002,420,0001,813,0002,781,9521,744,78948,2532,236,000
Interest Payable6,00041,00015,00010,00044,0006,00011,00047,00025,00039,00034,00050,00028,00047,00082,000
Interest Receivable896,00081,00010,0007,0009,0003,00070,00033,00027,00025,00086,00074,00031,000108,000
Pre-Tax Profit4,834,0002,910,0003,693,0004,505,0002,705,0002,586,0001,655,0001,926,0003,725,0002,408,0001,804,0002,401,0001,571,0003,612,0002,262,000
Tax-1,145,000-535,000-698,000-877,000-538,000-493,00061,000-375,000-764,000-535,000-457,000-346,000-275,000-3,574,000-672,000
Profit After Tax3,689,0002,375,0002,995,0003,628,0002,167,0002,093,0001,716,0001,551,0002,961,0001,873,0001,347,0002,055,0001,296,00038,0001,590,000
Dividends Paid200,0001,200,0001,873,0001,824,0004,000,000
Retained Profit3,689,0002,375,0002,995,0003,428,000967,0002,093,0001,716,0001,551,0001,088,00049,000-2,653,0002,055,0001,296,00038,0001,590,000
Employee Costs11,649,00012,717,00011,131,00010,429,00010,305,00010,202,0009,783,0007,415,0005,549,0006,321,0006,076,0005,527,0005,172,0004,708,0004,208,000
Number Of Employees96101979410195988670687878727062
EBITDA*3,950,0002,894,0003,732,0004,537,0002,783,0002,723,0001,707,0001,925,0003,737,0002,460,0001,863,0002,825,9521,771,78997,2532,303,000

* Earnings Before Interest, Tax, Depreciation and Amortisation

Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Tangible Assets446,000372,000143,00026,00045,00065,00029,00016,00052,000161,000109,000114,000128,000
Intangible Assets159,000228,00030,00054,00078,000102,000120,000120,0001,0005,00012,00015,00026,000
Investments & Other36,000105,00090,000
Debtors (Due After 1 year)2,919,000
Total Fixed Assets3,114,000333,000566,000426,000221,000128,000165,000185,00029,00017,00057,000173,000124,000140,000128,000
Stock & work in progress21,973,00015,790,00014,430,00025,239,00013,720,00010,291,0007,361,0005,330,0004,370,0003,991,0004,214,0003,594,0004,639,0002,375,0008,725,000
Trade Debtors23,529,00023,717,00024,176,00024,204,00022,441,00018,203,00016,388,00012,855,00011,942,00011,602,0009,204,00038,000
Group Debtors10,798,0009,714,000818,00012,0001,415,00059,0003,277,000549,000292,0004,844,00010,191,0003,157,0007,527,000
Misc Debtors416,0001,178,000894,000341,000919,000572,000849,000319,000455,000327,000551,0008,608,0008,334,0008,017,0008,164,000
Cash1,00034,0001,462,000247,0001,266,0001,587,0001,934,000691,0001,119,000
misc current assets100,000322,000590,000
total current assets56,716,00050,399,00040,318,00049,796,00037,080,00030,482,00024,657,00021,815,00018,778,00016,459,00015,235,00018,733,00025,420,00014,830,00025,573,000
total assets59,830,00050,732,00040,884,00050,222,00037,301,00030,610,00024,822,00022,000,00018,807,00016,476,00015,292,00018,906,00025,544,00014,970,00025,701,000
Bank overdraft43,0002,671,000
Bank loan
Trade Creditors 2,052,0001,342,0001,182,000836,000909,0001,602,0001,066,0001,233,000664,000919,00011,955,0005,549,00010,741,0009,461,0007,625,000
Group/Directors Accounts25,546,00012,460,0009,856,00023,851,00018,443,00014,116,0009,924,00010,018,0008,404,0008,584,00013,331,000
other short term finances
hp & lease commitments91,000167,000228,000149,00078,000
other current liabilities8,794,00017,072,00012,181,00010,940,0007,021,0005,069,0006,102,0004,735,0005,258,0003,598,0004,694,00010,879,0002,881,0002,155,000
total current liabilities36,483,00031,084,00023,447,00035,776,00026,451,00020,787,00017,092,00015,986,00014,326,00013,101,00011,955,00012,914,00021,620,00012,342,00023,111,000
loans
hp & lease commitments70,00060,000224,000228,00060,000
Accruals and Deferred Income18,00011,000
other liabilities
provisions26,000
total long term liabilities70,00060,000224,000228,00060,00018,00011,00013,000
total liabilities36,553,00031,144,00023,671,00036,004,00026,511,00020,787,00017,092,00015,986,00014,344,00013,101,00011,966,00012,927,00021,620,00012,342,00023,111,000
net assets23,277,00019,588,00017,213,00014,218,00010,790,0009,823,0007,730,0006,014,0004,463,0003,375,0003,326,0005,979,0003,924,0002,628,0002,590,000
total shareholders funds23,277,00019,588,00017,213,00014,218,00010,790,0009,823,0007,730,0006,014,0004,463,0003,375,0003,326,0005,979,0003,924,0002,628,0002,590,000
Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
Operating Activities
Operating Profit3,944,0002,870,0003,708,0004,505,0002,742,0002,583,0001,663,0001,903,0003,717,0002,420,0001,813,0002,781,9521,744,78948,2532,236,000
Depreciation8,00017,000122,00026,00022,00019,00036,00043,00044,00027,00049,00067,000
Amortisation6,00024,00024,00024,00024,00018,00018,0001,0004,0007,000
Tax-1,145,000-535,000-698,000-877,000-538,000-493,00061,000-375,000-764,000-535,000-457,000-346,000-275,000-3,574,000-672,000
Stock6,183,0001,360,000-10,809,00011,519,0003,429,0002,930,0002,031,000960,000379,000-223,000620,000-1,045,0002,264,000-6,350,0008,725,000
Debtors3,053,0008,721,0001,331,0001,197,0003,170,0002,894,000845,0003,505,000725,0002,466,000-3,697,000-5,073,0007,351,000-4,555,00015,729,000
Creditors710,000160,000346,000-73,000-693,000536,000-167,000569,000-255,000-11,036,0006,406,000-5,192,0001,280,0001,836,0007,625,000
Accruals and Deferred Income-8,278,0004,891,0001,241,0003,919,0001,952,000-1,033,0001,367,000-541,0001,678,0003,587,000-4,683,000-6,185,0007,998,000726,0002,155,000
Deferred Taxes & Provisions-26,00026,000
Cash flow from operations-13,999,000-2,671,00014,099,000-5,210,000-3,095,000-4,091,00092,000-2,887,0003,292,000-7,767,0006,180,000-2,753,0481,159,7899,990,253-13,043,000
Investing Activities
capital expenditure63,000224,000-74,000-237,000-134,000-103,000-24,000-178,000-32,00066,000-93,000-11,000-61,000-195,000
Change in Investments-69,00015,00090,000
cash flow from investments132,000209,000-164,000-237,000-134,000-103,000-24,000-178,000-32,00066,000-93,000-11,000-61,000-195,000
Financing Activities
Bank loans
Group/Directors Accounts13,086,0002,604,000-13,995,0005,408,0004,327,0004,192,000-94,0001,614,000-180,0008,584,000-13,331,00013,331,000
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments-66,000-225,00075,000239,000138,000
other long term liabilities
share issue1,000,000
interest890,00040,000-15,000-37,0003,000-8,00023,0008,000-12,000-9,00036,00046,000-16,00026,000
cash flow from financing13,910,0002,419,000-13,935,0005,647,0004,428,0004,195,000-102,0001,637,000-172,0008,572,000-9,00036,00046,000-13,347,00014,357,000
cash and cash equivalents
cash-1,0001,000-34,000-1,428,0001,215,000-1,019,000-321,000-347,0001,243,000-428,0001,119,000
overdraft-43,00043,000-2,671,0002,671,000
change in cash43,000-43,000-1,0001,000-34,000-1,428,0001,215,000-1,019,0002,350,000-3,018,0001,243,000-428,0001,119,000

ipsen limited Credit Report and Business Information

Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for ipsen limited. Get real-time insights into ipsen limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Ipsen Limited Competitor Analysis

competitor_analysis_table_img

Perform a competitor analysis for ipsen limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mega companies, companies in W 2 area or any other competitors across 12 key performance metrics.

ipsen limited Ownership

IPSEN LIMITED group structure

Ipsen Limited has no subsidiary companies.

Ultimate parent company

ISPEN SA

#0134602

ISPEN PHARMA SAS

#0134596

2 parents

IPSEN LIMITED

06751069

IPSEN LIMITED Shareholders

sutrepa sas 100%

ipsen limited directors

Ipsen Limited currently has 6 directors. The longest serving directors include Chrisitian De La Tour (Jan 2009) and Dr John Chaddock (Apr 2021).

officercountryagestartendrole
Chrisitian De La Tour65 years Jan 2009- Director
Dr John ChaddockEngland56 years Apr 2021- Director
Mr Alexandre VisciglioUnited Kingdom46 years May 2021- Director
Mr Alexandre VisciglioUnited Kingdom46 years May 2021- Director
Lynne Millar-KellyUnited Kingdom41 years Mar 2022- Director
Ioana ParsonsEngland46 years Mar 2024- Director

P&L

December 2023

turnover

122.4m

+14%

operating profit

3.9m

+37%

gross margin

25.6%

-11.85%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

December 2023

net assets

23.3m

+0.19%

total assets

59.8m

+0.18%

cash

0

0%

net assets

Total assets minus all liabilities

ipsen limited company details

company number

06751069

Type

Private limited with Share Capital

industry

46460 - Wholesale of pharmaceutical goods

incorporation date

November 2008

age

17

incorporated

UK

ultimate parent company

ISPEN SA

accounts

Full Accounts

last accounts submitted

December 2023

previous names

ipsen developments limited (December 2008)

accountant

-

auditor

CONSTANTIN

address

5th floor the point, 37 north wharf road, london, W2 1AF

Bank

-

Legal Advisor

-

ipsen limited Charges & Mortgages

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to ipsen limited.

ipsen limited Capital Raised & Share Issues BETA

When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.

Click to start generating capital raising & share issue transactions for IPSEN LIMITED. This can take several minutes, an email will notify you when this has completed.

ipsen limited Companies House Filings - See Documents

datedescriptionview/download